rendered_image.png20210521-6-10jfy19 (1)
Since Career Communications Group (CCG) launched High-Tech Sunday in June 2020, CCG has released three podcasts featuring the lives and careers of women in biomedical careers.
If you haven't already, please take the opportunity to listen to all three podcasts, which ran for the first time between November 2020 and April 2021.
High-Tech Sunday is released every Sunday at 3 p.m. The weekly program is produced by and for Career Communications Group’s community of professionals in science, technology, engineering, and math (STEM) fields, thought leaders, and students, to bring a concentrated discussion around technological advancements and achievements based on universal moral principles.
Colletta Orr, an award-winning cancer research scientist, CEO, author, and science communicator, has held various careers in her STEM pathway. Having seen the devastating effects of hereditary cancer in her family, she made it a mission to understand and fight breast and ovarian cancer. As a research scientist, Colletta held positions at Georgetown University Lombardi Cancer Center and The National Cancer Institute. She worked as a bench scientist for 15 years doing basic research. More recently, she has served as a cancer consultant, working with hospitals to develop informational programs for cancer survivors. She has partnerships with major hospitals throughout the United States, and with pharmaceutical companies. As a scientific writer and community liaison, she translates what's been done in the laboratory to the public.
Cancer treatment pioneer Hadiyah-Nicole Green is introducing the world to the next generation of cancer treatments and affordable healthcare through her expertise in physics, nanomedicine, immunotherapy, and precision medicine. Dr. Green received the Professional Achievement in Industry Award at the 2018 Women of Color STEM Conference. In this podcast, Dr. Green talks about how she developed a revolutionary cancer treatment that uses lasers and nanotechnology to eliminate cancer in mice after one 10-minute treatment in just 15 days with no observable side effects.
Biomedical Engineer and STEM Advocate Korie Grayson is a postdoctoral research fellow at the University of Michigan's department of chemical engineering. Her research is focused on the evaluation of novel nano- and microparticles for therapy in neutrophilic, acute inflammatory disease, and cancer. Korie is a passionate diversity advocate in STEM. She earned her bachelor's degree in chemistry at Norfolk State University in 2012, and a master's degree and Ph.D. in biomedical engineering from Cornell University. To date, Korie has received several awards, including the National Science Foundation Graduate Research Fellowship (2014), Alfred P. Sloan Diversity Fellowship (2014), Robert Mozia Graduate Distinguished Service Award (2016), and Graduate Student of the Year (2017) from the Diversity Programs in Engineering Department at Cornell University. She was recently inducted into the Edward A. Bouchet Graduate Honor Society (2020).